telepathology
(3)
The Pathology Scanner That Changed the Invoice
A pathology slide still begins as a piece of glass. OptraSCAN wants the expensive part of turning it into a shareable, analyzable image to feel less like buying a machine and more like using a service.
Gestalt Spent Eight Years Building the Boring Layer of Pathology - Now AI Has Somewhere Useful to Work
Most pathology AI companies sell the clever answer. Gestalt sells the place where the slide, the case, the pathologist and competing algorithms can finally meet - a workflow-first bet backed by a $7.5 million Series A.
Morphle Labs Inc.
Morphle Labs is a deep-tech healthcare automation company building robotic and AI-driven imaging systems for cancer diagnostics. Founded in 2017 and now operating between Bengaluru and New York, it combines robotics, optical engineering, and neural-network AI to automate the historically manual steps of histology - from tissue sectioning to whole-slide scanning to remote reporting. Its product line spans the RoboTome robotic microtome, the MorphoLens family of whole-slide scanners, and the HemoLens hematology scanners, giving pathology labs an end-to-end digital workflow at a fraction of the cost of legacy systems.